Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism-Reference-Cited by-同舟云学术

Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism

Published:2023 Issue:5 Volume:70 Page:489-500
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Kobayashi Hiroki¹,Nakamura Yoshihiro¹,Abe Masanori¹,Tanabe Akiyo²,Sone Masakatsu³,Katabami Takuyuki⁴,Kurihara Isao⁵,Ichijo Takamasa⁶,Tsuiki Mika⁷,Izawa Shoichiro⁸,Wada Norio⁹,Yoneda Takashi¹⁰,Takahashi Katsutoshi¹¹,Tamura Kouichi¹²,Ogawa Yoshihiro¹³,Inagaki Nobuya¹⁴,Yamamoto Koichi¹⁵,Rakugi Hiromi¹⁵,Naruse Mitsuhide⁷,

Affiliation:

1. Division of Nephrology, Hypertension, and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan

2. Division of Endocrinology, National Center for Global Health and Medicine, Tokyo 162-8655, Japan

3. Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan

4. Division of Metabolism and Endocrinology, Department of Internal Medicine, St Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama 241-0811, Japan

5. Department of Medical Education, National Defense Medical College, Tokorozawa 359-8513, Japan

6. Department of Endocrinology and Metabolism, Saiseikai Yokohamashi Tobu Hospital, Yokohama 230-8765, Japan

7. Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan

8. Division of Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago 683-8504, Japan

9. Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo 060-8604, Japan

10. Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-0934, Japan

11. Division of Metabolism, Showa General Hospital, Kodaira 187-0002, Japan

12. Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan

13. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan

14. Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan

15. Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/70/5/70_EJ22-0585/_pdf

Reference33 articles.

1. 1 Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193–202.

2. 2 Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045–1050.

3. 3 Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, et al. (2006). A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48: 2293–2300.

4. 4 Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, et al. (2017) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69: 1811–1820.

5. 5 Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, et al. (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168: 80–85.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Historical changes in the clinical features of primary aldosteronism;Hypertension Research;2024-08-08

2. Prevalence of unilateral hyperaldosteronism in primary aldosteronism: impact of a novel chemiluminescent immunoassay for measuring plasma aldosterone in Japan;Hypertension Research;2024-07-29

3. Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study;Hypertension Research;2024-03-08

4. Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) <i>via</i> retrospective analyses in Okinawa, Japan;Endocrine Journal;2024

5. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism;Endocrine;2023-12-12